Humacyte Inc (HUMA)
7.16
-0.05
(-0.69%)
USD |
NASDAQ |
May 24, 16:00
7.34
+0.18
(+2.51%)
After-Hours: 19:56
Humacyte Accounts Payable (Quarterly): 3.452M for March 31, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 3.452M |
| December 31, 2023 | 6.49M |
| September 30, 2023 | 3.018M |
| June 30, 2023 | 2.362M |
| March 31, 2023 | 1.954M |
| December 31, 2022 | 1.595M |
| Date | Value |
|---|---|
| September 30, 2022 | 3.255M |
| June 30, 2022 | 2.537M |
| March 31, 2022 | 3.037M |
| December 31, 2021 | 2.094M |
| September 30, 2021 | 5.83M |
| December 31, 2020 | 2.274M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
1.595M
Minimum
Dec 2022
6.49M
Maximum
Dec 2023
3.158M
Average
2.778M
Median
Accounts Payable (Quarterly) Benchmarks
| Aquestive Therapeutics Inc | 10.52M |
| Adial Pharmaceuticals Inc | 0.1775M |
| Gritstone Bio Inc | 7.248M |
| Precision BioSciences Inc | 1.136M |
| Puma Biotechnology Inc | 8.964M |